S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Most profitable less than $5 stock in the world? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Pipeline break spills 45,000 gallons of diesel in Wyoming
2 Important Retail Stock Battles to Watch
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Judge revives Obama-era ban on coal sales from federal lands
In Biden's big bill: Climate, health care, deficit reduction
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Most profitable less than $5 stock in the world? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Pipeline break spills 45,000 gallons of diesel in Wyoming
2 Important Retail Stock Battles to Watch
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Judge revives Obama-era ban on coal sales from federal lands
In Biden's big bill: Climate, health care, deficit reduction
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Most profitable less than $5 stock in the world? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Pipeline break spills 45,000 gallons of diesel in Wyoming
2 Important Retail Stock Battles to Watch
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Judge revives Obama-era ban on coal sales from federal lands
In Biden's big bill: Climate, health care, deficit reduction
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Most profitable less than $5 stock in the world? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Pipeline break spills 45,000 gallons of diesel in Wyoming
2 Important Retail Stock Battles to Watch
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Judge revives Obama-era ban on coal sales from federal lands
In Biden's big bill: Climate, health care, deficit reduction
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
NASDAQ:NBIX

Neurocrine Biosciences - NBIX Earnings Date, Estimates & Call Transcripts

$105.63
+0.75 (+0.72%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$105.19
$106.96
50-Day Range
$88.93
$107.66
52-Week Range
$71.88
$109.26
Volume
1.23 million shs
Average Volume
746,506 shs
Market Capitalization
$10.10 billion
P/E Ratio
960.36
Dividend Yield
N/A
Price Target
$113.60
Skip Charts & View Estimated and Actual Earnings Data

NBIX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NBIX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Neurocrine Biosciences Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20225$0.19$0.50$0.35 
Q2 20225$0.47$0.79$0.61 
Q3 20225$0.59$0.75$0.65 
Q4 20225$0.59$0.88$0.73 
FY 202220$1.84$2.92$2.35 
Q1 20232$0.51$0.72$0.62 
Q2 20232$0.74$1.00$0.87 
Q3 20233$0.93$1.16$1.05 
Q4 20233$1.12$1.31$1.24 
FY 202310$3.30$4.19 $3.78

NBIX Earnings Date and Information

Neurocrine Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 7th, 2022 based off prior year's report dates.

Neurocrine Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/7/2022
(Estimated)
        
5/4/2022Q1 2022$0.33$0.14($0.19)$0.14$304.07 million$310.60 million      
2/11/2022Q4 2021$0.61($0.08)($0.69)($0.08)$317.72 million$312.00 million    
11/1/20219/30/2021$0.51$0.23($0.28)$0.23$297.02 million$296.00 million    
8/2/20216/30/2021$0.52$0.43($0.09)$0.43$274.47 million$288.90 million    
5/4/20213/31/2021$0.47$0.33($0.14)$0.33$247.81 million$236.60 million    
2/3/202112/31/2020$0.59$3.58+$2.99$3.58$260.43 million$247.90 million  
11/14/20209/30/2020$0.11($0.62)($0.73)($0.62)$282.59 million$258.80 million    
8/3/20206/30/2020$0.65$0.81+$0.16$0.81$261.66 million$302.40 million    
5/6/20203/31/2020$0.56$0.82+$0.26$1.25$226.29 million$237.10 million  
2/4/2020Q4 19$0.75$0.35($0.40)$0.35$231.54 million$244.10 million  
11/4/2019Q3 2019$0.63$0.56($0.07)$1.02$211.31 million$222.09 million  
7/29/2019Q2$0.24$0.37+$0.13$0.20$161.79 million$183.58 million  
4/29/20193/31/2019($1.05)($1.12)($0.07)($1.12)$136.77 million$138.40 million  
2/5/201912/31/2018$0.14$0.19+$0.05$0.19$132.32 million$131.49 million
11/5/20189/30/2018$0.48$0.52+$0.04$0.52$151.51 million$151.80 million  
7/31/2018Q2 2018($0.18)($0.07)+$0.11($0.07)$84.11 million$96.90 million
4/30/2018Q1 2018($0.29)($0.47)($0.18)($0.47)$65.17 million$71.08 million  
2/13/2018Q4 2017$0.18$0.07($0.11)$0.07$94.00 million$94.52 million  
11/1/2017Q3 2017($0.49)($0.13)+$0.36($0.13)$29.38 million$60.77 million
8/3/2017Q2 17($0.67)($0.68)($0.01)($0.68)$0.61 million$6.34 million  
5/9/2017Q1 17($0.67)($0.90)($0.23)($0.90)$3.00 million  
2/14/2017Q416($0.55)($0.51)+$0.04($0.51)$4.55 million  
11/2/2016Q316($0.57)($0.43)+$0.14($0.43)
8/3/2016Q2 2016($0.50)($0.46)+$0.04($0.46)
5/5/2016Q1($0.29)($0.22)+$0.07($0.22)$15.43 million$15.00 million
2/11/2016Q415($0.32)($0.34)($0.02)($0.34)$3.33 million  
10/29/2015Q315($0.25)($0.40)($0.15)($0.40)$6.66 million  
7/29/2015Q2($0.2860)($0.28)+$0.0060($0.28)$0.41 million  
4/30/2015Q115($0.30)($0.01)+$0.29($0.01)$19.76 million
2/9/2015Q414($0.24)($0.26)($0.02)($0.26)
11/3/2014Q314($0.21)($0.21)($0.21)
8/6/2014Q214($0.18)($0.18)($0.18)$0.12 million  
4/30/2014Q114($0.19)($0.17)+$0.02($0.17)$0.78 million  
2/6/2014Q4 2013($0.17)($0.16)+$0.01($0.16)$0.79 million$0.73 million
10/29/2013Q3 2013($0.20)($0.17)+$0.03($0.17)$0.79 million$0.73 million  
7/25/2013Q2 2013($0.20)($0.18)+$0.02($0.18)$0.77 million$0.73 million  
5/2/2013Q1 2013($0.18)($0.18)($0.18)$1.07 million$0.70 million  
2/8/2013Q4 2012($0.08)$0.14+$0.22$9.43 million$21.90 million  
10/31/2012Q312($0.05)($0.05)$10.28 million$9.40 million
7/31/2012($0.03)($0.01)+$0.02
5/2/2012($0.01)($0.01)  
2/8/2012Q4 2011$0.01$0.02+$0.01$0.02
10/31/2011$0.19$0.56+$0.37  
7/28/2011$0.04$0.04
5/3/2011$0.05$0.05
2/10/2011$0.04$0.05+$0.01
10/28/2010Q3 2010$0.05$0.06+$0.01$0.06
7/28/2010Q2 2010($0.17)($0.09)+$0.08($0.09)
4/28/2010Q1 2010($0.24)($0.20)+$0.04($0.21)
2/3/2010Q4 2009($0.28)($0.22)+$0.06($0.24)
10/28/2009Q3 2009($0.35)($0.21)+$0.14($0.21)
7/29/2009Q2 2009($0.41)($0.37)+$0.04($0.35)
5/5/2009Q1 2009($0.38)($0.38)($0.25)
2/3/2009Q4 2008($0.47)($0.75)($0.28)($0.75)
10/28/2008Q3 2008($0.52)($0.46)+$0.06($0.46)
7/30/2008Q2 2008($0.52)($0.55)($0.03)($0.55)
4/30/2008Q1 2008($0.54)($0.55)($0.01)($0.55)
2/5/2008Q4 2007($0.84)($0.71)+$0.13$1.93












Neurocrine Biosciences Earnings - Frequently Asked Questions

When is Neurocrine Biosciences's earnings date?

Neurocrine Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 7th, 2022 based off last year's report dates. Learn more on NBIX's earnings history.

How much revenue does Neurocrine Biosciences generate each year?

Neurocrine Biosciences (NASDAQ:NBIX) has a recorded annual revenue of $1.13 billion.

How much profit does Neurocrine Biosciences generate each year?

Neurocrine Biosciences (NASDAQ:NBIX) has a recorded net income of $89.60 million. NBIX has generated $0.11 earnings per share over the last four quarters.

What is Neurocrine Biosciences's price-to-earnings ratio?

Neurocrine Biosciences (NASDAQ:NBIX) has a trailing price-to-earnings ratio of 960.36 and a forward price-to-earnings ratio of 60.02.

What is Neurocrine Biosciences's EPS forecast for next year?

Neurocrine Biosciences's earnings are expected to grow from $1.76 per share to $3.88 per share in the next year, which is a 120.45% increase.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:NBIX) was last updated on 8/13/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.